Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion

Sònia Solé1, Valérie Petegnief, Roser Gorina

  • 1Departament de Farmacologia i Toxicologia, IIBB-CSIC, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Insights

Matrix metalloproteinase-3 (MMP-3) activation after stroke cleaves neuronal agrin. This study reveals MMP-3

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Matrix metalloproteinase-3 (MMP-3) degrades extracellular matrix components.
  • MMP-3 may play a role in stroke pathogenesis.

Purpose of the Study:

  • To examine MMP-3 expression, activation, and cellular location.
  • To investigate MMP-3's role in cleaving agrin, an MMP-3 substrate, after stroke.

Main Methods:

  • Transient middle cerebral artery occlusion in rats.
  • Cell culture studies of MMP-3 expression.
  • Casein zymography.
  • Western blotting for agrin and cleaved fragments.

Main Results:

  • Ischemia/reperfusion activated MMP-3, indicated by cleaved forms and substrate degradation.
  • MMP-3 was found in ischemic neurons, oligodendrocytes, microvasculature, and reactive microglia/macrophages.
  • MMP-3 addition to brain extracts caused neuronal agrin degradation; ischemia led to agrin cleavage and membrane disappearance.

Conclusions:

  • Ischemia/reperfusion activates MMP-3 in the brain.
  • Activated MMP-3 cleaves neuronal transmembrane agrin.
  • Ischemia-induced MMP-3 activation is a likely cause of agrin cleavage in stroke.